Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    WS04 - IASLC/IMIG Workshop - The Future of Mesothelioma Treatment

    • 08:00 - 11:00
    • 8/06/2022
    • Location: Lehar 4
    • Not for CME Credit
    • Type: Workshop
    • Track: N/A
    • +

      WS04.15 - Panel - Everything You Wanted to Know About Mesothelioma but Were Afraid to Ask

      11:00 - 11:00  |  Presenter: Andreas Rimner

      • Abstract

      Loading...

  • +

    IBS06 - Which Therapy for Which MPM Patient? (Ticketed Session) (In-person Access Only)

    • 07:30 - 08:15
    • 8/07/2022
    • Location: Lehar 4
    • IASLC CME Accredited
    • Type: Interactive Breakfast Session
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
    • +

      IBS06.03 - Local Treatments for Meso - Radiotherapy

      07:45 - 08:00  |  Presenter: Andreas Rimner

      • Abstract

      Loading...

  • +

    EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
    • +

      EP05.01-014 - Circulating Tumor DNA to Identify Genomic Biomarkers of Radiation Sensitivity in Locally Advanced Non-Small Cell Lung Cancer

      Presenter: Emily Lebow

      • Abstract

      Loading...

    • +

      EP05.01-025 - Planned Interim Analysis of a Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung Cancer

      Presenter: Andreas Rimner

      • Abstract

      Loading...

  • +

    EP07.01 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
    • +

      EP07.01-018 - Phase III Randomized Trial on Surgery, Chemo and Pleural Radiation (IMPRINT) for Resectable Pleural Mesothelioma (NRG LU-006)

      Presenter: Andreas Rimner

      • Abstract

      Loading...

  • +

    P1.05 - Early Stage Non-small Cell - Biomarkers

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Early Stage Non-small Cell - Biomarkers
    • +

      P1.05-02 - Mutations in CREBBP are Associated with Local Failure after Lung Stereotactic Body Radiation Therapy

      Presenter: Victor Chan Ng

      • Abstract

      Loading...